Type 1 diabetes occurs when the immune system becomes activated against the pancreatic β cells, leading to deficiency of the hormone insulin and chronically elevated blood glucose levels.  Our research is focused on understanding the molecular pathways in the β cells that contribute to type 1 diabetes development, with the goal of targeting these pathways to help preserve insulin secretion in those with or at risk of type 1 diabetes.